Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Relay Therapeutics Inc
About RLAY
Relay Therapeutics Inc. is a clinical-stage precision medicine company. The Company’s initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. Its Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The Company’s lead product candidates, such as RLY-2608. It is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including RLY-2608. RLY-2608 is an allosteric, pan-mutant and isoform-selective phosphoinostide 3 kinase alphas (PI3Kα), inhibitor in clinical development. It is the lead program in its efforts to discover and develop mutant selective inhibitors of PI3Kα.
Find out what a historical investment in Relay Therapeutics Inc would be worth today using our RLAY stock calculator.
Market Capitalisation
$2.34B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.47M
High today
$12.72
Low today
$12.19
Open price
$12.59
52-week high
$17.32
52-week low
$2.67
Ready to start your investing journey with Stake?
Open an accountHow do I buy RLAY shares in Australia?
Buying RLAY shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Relay Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RLAY
What is the ticker symbol of Relay Therapeutics Inc?
The ticker symbol for Relay Therapeutics Inc is RLAY.
How much is one share of RLAY?
One share of RLAY is valued at $12.28 as of 16 May 2026.
What is the market capitalisation of Relay Therapeutics Inc RLAY?
As of 16 May 2026 Relay Therapeutics Inc has a market cap of $2.34B.
What is the 52-week high for Relay Therapeutics Inc stock?
The Relay Therapeutics Inc 52-week high stock price is $17.32.
What is the 52-week low for Relay Therapeutics Inc stock?
The Relay Therapeutics Inc 52-week low stock price is $2.67.
Can I buy RLAY shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RLAY shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RLAY on Stake
- Buy RLAY from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RLAY from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RLAY related stocks